Wes Wheeler Diangkat sebagai CEO oleh Dewan Direksi Marken

AsiaNet 44774

LONDON, 26 Mei 2011 /PRNewswire-AsiaNet/ —

Dewan Direksi Marken berkenan mengumumkan pengangkatan Wesley P. Wheeler,
MBA sebagai Chief Executive Officer. Pak Wheeler menggantikan Gerard Barba,
yang akan tetap menjadi Ketua Dewan Direksi Marken.

Dewan Direksi dan tim manajemen eksekutif Marken berupaya menambahkan
eksekutif seperti Pak Wheeler karena kedalaman pengalamannya dalam industri
ilmu hayat maupun latar belakang yang kuat di bidang logistik untuk lebih
memperkuat kepemimpinan pasar dan mempertahankan pertumbuhan solid Marken.

Sebelum bergabung dengan Marken, Wes menjabat Presiden dan CEO Patheon
Inc., perusahaan jasa manufaktur kontrak terkemuka. Wes juga mantan Presiden
Valeant Pharmaceuticals International, dan sebelumnya menduduki jabatan
eksekutif senior yang bertanggung jawab di bidang manufaktur, pemasaran dan
teknik di GlaxoSmithKline, plc. Sebelum berkarir selama 22 tahun di bidang
farmasi, Pak Wheeler sukses menjalani masa karir 12 tahun di ExxonMobil. Ia
meraih gelar sarjana di bidang Teknik Mesin dan Master of Business
Administration.

“Karena sifat litbang biofarmasi berubah-ubah, rantai pasokan klinis yang
terkontrol dengan baik akan menjadi faktor signifikan dalam keberhasilan
perusahaan ilmu hayat penting dan industri pendukungnya. Dewan Direksi dan saya
merasa bahwa Wes dapat membawa pengalamannya dari industri pembuatan obat,
bioteknologi dan farmasi tradisional untuk menambah tim manajemen yang sudah
kuat dan melanjutkan pertumbuhan Marken,” kata Gerard Barba, Presiden Komisaris
Marken.

Bapak Khawar Mann, managing partner, APAX LLP, berkata: “Kami senang bahwa
Wes telah setuju bergabung dengan kami di Marken. Latar belakang operasi dan
rekam jejaknya yang berhasil dalam industri farmasi akan memberi kami alat yang
kami butuhkan untuk terus membangun portofolio jasa dan geografi Marken, dan
dengan demikian mewujudkan potensi terbesar kami sebagai penyedia jasa logistik
terkemuka.”

Tentang Marken
Marken, yang didirikan pada tahun 1980, difokuskan untuk mendukung
logistik perusahaan Ilmu Hayat. Mereka mengelola pengumpulan, transportasi,
penyimpanan dan distribusi global serta pasokan spesimen ujicoba klinis. Selain
melalui jaringan depot mereka, Marken mendukung penyimpanan dan distribusi
regional bahan ilmu hayat. Anggota tim dan jaringan fasilitas Marken
menjembatani jarak antara pasien dan sumber daya penting perusahaan ilmu hayat.

http://www.marken.com

SUMBER: Marken

KONTAK:
Elan Josielewski,
Elan.Josielewski@marken.com,
+1-347-855-3526,
www.marken.com

………………………………………………………………………………………………………….

Wes Wheeler Appointed as CEO by Marken’s Board of Directors

LONDON, May 26, 2011 /PRNewswire-AsiaNet/ —

The Marken Board of Directors is pleased to announce the appointment of Wesley P. Wheeler, MBA as Chief Executive Officer. Mr. Wheeler succeeds Gerard Barba, who will remain the Chairman of the Marken Board of Directors.

Marken’s Board and executive management team have sought to add an executive such as Mr. Wheeler for his depth of experience in the life science industry as well as a strong background in logistics to further strengthen market leadership and maintain Marken’s solid growth path.

Prior to joining Marken, Wes held the title of President and CEO of Patheon Inc., a top contract manufacturing services company. Wes was also a former President of Valeant Pharmaceuticals International, and has previously held senior executive roles of increasing responsibility in manufacturing, marketing and engineering at GlaxoSmithKline, plc. Preceding his 22 year career in pharmaceuticals, Mr. Wheeler had a successful 12 year career at ExxonMobil. He holds a bachelor’s degree in Mechanical Engineering and a Masters of Business Administration.

“As the nature of biopharmaceutical R&D changes, well controlled clinical supply chains will be a significant factor in the success of key life science companies and the industries that support them. The Board and I feel that Wes can bring his experience from the drug manufacturing, biotechnology and traditional pharmaceutical industries to augment an already strong management team and continue Marken’s growth,” said Gerard Barba, Marken’s Chairman.

Mr. Khawar Mann, managing partner, APAX LLP., said: “We are delighted that Wes has agreed to join us at Marken. His operations background and successful track record in the pharmaceutical industry will give us the tools we need to continue building Marken’s portfolio of services and geographies, and thus realize our greatest potential as a leading logistics services provider.”

About Marken
Founded in 1980, Marken is focused on supporting the logistics of life Science companies. They manage the global collection, transportation, storage and distribution of specimens and clinical trial supplies. Additionally through their depot network, Marken supports regional storage and distribution of life science materials. Marken’s team members and network of facilities bridge the distance between patients and the essential resources of life science companies.

http://www.marken.com

SOURCE: Marken

CONTACT:
Elan Josielewski,
Elan.Josielewski@marken.com,
+1-347-855-3526,
www.marken.com